z-logo
open-access-imgOpen Access
Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study
Author(s) -
LC Coates,
Gladman Dd,
Peter Nash,
Oliver FitzGerald,
Arthur Kavanaugh,
Lawrence Rasouliyan,
Luminita Pricop,
Kevin Ding,
Corine Gaillez
Publication year - 2018
Publication title -
skin
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.17
Subject(s) - secukinumab , psoriatic arthritis , medicine , phase (matter) , arthritis , dermatology , chemistry , organic chemistry
not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here